Abstract:Introduction Balancing immunity and immunopathology at the sites of inflammation requires coordination of effector and regulatory immune mechanisms. Local immune responses to the infection, mechanical insult or an allograft result in the release of inflammatory mediators such as TLR ligands or proinflammatory cytokines. The ability of regulatory T cells (Treg) cells to respond to and suppress in the presence of inflammatory mediators is still not fully understood. From the perspective of clinical translation of Treg cell therapy for the organ transplantation, the investigation of the ability of Treg cells to mediate suppression in inflammatory conditions is extremely important. In this study, we investigated the impact of physiological amounts of IL-1&bgr; on Treg-mediated suppression and role of a decoy IL-1 receptor (IL-1RII) in Tregs ability to regulate the immune response. Material and Methods Sorted CD127loCD25+CD4+ human Tregs and CD127+CD25-CD4+ T effector cells (Teffs) have been expanded in vitro in the presence of anti-CD3/CD28 beads and recombinant IL-2 and the expression of IL-1 receptors have been evaluated using qPCR. Using co-culture experiments we tested the effects of IL-1&bgr; on the alloresponse and Tregs suppression. Next, utilising lentiviral IL-1RII silencing, neutralising antibodies and a combination of proliferation assays, intracellular signalling and cytokine production measurements we assessed the role of IL-1RII in human Tregs. Results Here, we demonstrated that physiological amounts of exogenousIL-1&bgr; significantly enhanced the proliferation and cytokine production by human T cells upon allostimulation. Interestingly, at high dose Tregs could neutralise the effect of IL-1&bgr; on both proliferation and cytokine secretion. When assessed for expression of IL-1 receptors, Treg cells responded to activation with increased expression of a decoy IL-1 receptor, IL-1RII, and by releasing soluble IL-1RII into the local microenvironment, whereas the expression of signal transducing receptor, IL-1RI, was similar in Treg and T effector cells. Next, using lentiviral silencing, we demonstrated that IL-1RII expression by human Tregs is necessary for efficient suppression of effector T cells proliferation and cytokine production, especially when tested in the presence of exogenous IL-1&bgr;. Conclusion We propose that the ability of Tregs to produce IL-1RII provides a decoy strategy to ensure regulation by modulating production of proinflammatory cytokines. As Treg cells present at the site of inflammation have important role in modulating the immune response, our data provide an important additional mechanism by which Treg cells ensure effective regulation in a proinflammatory microenvironment. European Society for Organ Transplantation, Junior Basic Science Research Grant.Kidney Research UK, SF1/2014.

The T-cell environment: may the regulatory force be with you

Impact of Regulatory T Cells on Innate Immune Cells in a Pre-Sensitized Heart Transplant Model

Gut Microbes Enlarged the Protective Effect of Transplanted Regulatory B Cells on Rejection of Cardiac Allografts.

T Regulatory Cells As an Immunotherapy for Transplantation

T regulatory cells as an immunotherapy for transplantation.

Regulatory T Cells in Transplantation Tolerance

Current status and perspectives of regulatory T cell-based therapy

In Vivo Environment Necessary to Support Transplanted Donor Mouse T Regulatory Cells

Tregs in transplantation tolerance: role and therapeutic potential

Induced Regulatory T Cells as Immunotherapy in Allotransplantation and Autoimmunity: Challenges and Opportunities

Non-human Primate Regulatory T Cells and Their Assessment as Cellular Therapeutics in Preclinical Transplantation Models

Dendritic Cells: Versatile Players in Renal Transplantation.

Intragraft regulatory T cells in the modern era: what can high-dimensional methods tell us about pathways to allograft acceptance?

B cells with regulatory properties in transplantation tolerance

Selective expansion of regulatory T cells using an orthogonal IL-2/IL-2 receptor system facilitates transplantation tolerance

Regulatory B Cells in Solid Organ Transplantation: From Immune Monitoring to Immunotherapy

Clinical adoptive regulatory T Cell therapy: State of the art, challenges, and prospective

Potential Application of T-Follicular Regulatory Cell Therapy in Transplantation

Treg cell-based therapies: challenges and perspectives

A Novel Mechanism of Human Regulatory T cell Function in Proinflammatory Conditions

Regulatory cell therapy for kidney transplantation and autoimmune kidney diseases